Original Publication Date: 1 October, 2014
Publication / Source: Future Oncology
Authors: Cheng-Har Yip, Anthony Rhodes
Breast cancer is the most common cancer in women worldwide. The majority of breast cancers show overexpression of estrogen receptors (ERs) and progesterone receptors (PRs). The development of drugs to target these hormone receptors, such as tamoxifen, has brought about significant improvement in survival for women with hormone receptor-positive breast cancers.